Mariner’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $106M | Buy |
357,919
+15,753
| +5% | +$4.68M | 0.12% | 145 |
|
|
2025
Q4 | $93.4M | Buy |
342,166
+62,727
| +22% | +$17M | 0.11% | 151 |
|
|
2025
Q3 | $75.5M | Buy |
279,439
+148,901
| +114% | +$40.5M | 0.1% | 169 |
|
|
2025
Q2 | $36M | Buy |
130,538
+20,434
| +19% | +$5.56M | 0.05% | 288 |
|
|
2025
Q1 | $29.2M | Buy |
110,104
+12,052
| +12% | +$2.97M | 0.05% | 293 |
|
|
2024
Q4 | $22.8M | Buy |
98,052
+4,024
| +4% | +$925K | 0.04% | 347 |
|
|
2024
Q3 | $20.7M | Buy |
94,028
+2,025
| +2% | +$419K | 0.04% | 360 |
|
|
2024
Q2 | $18.1M | Sell |
92,003
-164
| -0.2% | -$33.9K | 0.04% | 350 |
|
|
2024
Q1 | $19.8M | Buy |
92,167
+797
| +0.9% | +$167K | 0.04% | 331 |
|
|
2023
Q4 | $19.2M | Buy |
91,370
+2,418
| +3% | +$516K | 0.05% | 315 |
|
|
2023
Q3 | $17.8M | Buy |
88,952
+2,037
| +2% | +$405K | 0.05% | 308 |
|
|
2023
Q2 | $16.1M | Sell |
86,915
-1,780
| -2% | -$329K | 0.04% | 328 |
|
|
2023
Q1 | $17M | Buy |
88,695
+16,667
| +23% | +$3.01M | 0.05% | 321 |
|
|
2022
Q4 | $12.1M | Sell |
72,028
-3,212
| -4% | -$558K | 0.04% | 363 |
|
|
2022
Q3 | $13.3M | Buy |
75,240
+6,756
| +10% | +$1.34M | 0.05% | 298 |
|
|
2022
Q2 | $14M | Buy |
68,484
+829
| +1% | +$176K | 0.06% | 273 |
|
|
2022
Q1 | $16.1M | Buy |
67,655
+6,767
| +11% | +$1.59M | 0.06% | 265 |
|
|
2021
Q4 | $13.9M | Buy |
60,888
+1,415
| +2% | +$311K | 0.06% | 253 |
|
|
2021
Q3 | $11.5M | Buy |
59,473
+792
| +1% | +$160K | 0.06% | 258 |
|
|
2021
Q2 | $12.5M | Buy |
58,681
+3,715
| +7% | +$784K | 0.08% | 218 |
|
|
2021
Q1 | $11.2M | Sell |
54,966
-1,069
| -2% | -$211K | 0.08% | 215 |
|
|
2020
Q4 | $10.2M | Buy |
56,035
+4,989
| +10% | +$848K | 0.08% | 217 |
|
|
2020
Q3 | $8.54M | Sell |
51,046
-1,231
| -2% | -$207K | 0.08% | 208 |
|
|
2020
Q2 | $8.5M | Buy |
52,277
+157
| +0.3% | +$28.1K | 0.09% | 204 |
|
|
2020
Q1 | $9.02M | Buy |
+52,120
| New | +$10.4M | 0.11% | 179 |
|
|
2019
Q3 | – | Sell |
-8,604
| Closed | -$1.67M | – | 748 |
|
|
2019
Q2 | $1.67M | Buy |
8,604
+1,279
| +17% | +$236K | 0.02% | 425 |
|
|
2019
Q1 | $1.21M | Buy |
7,325
+992
| +16% | +$175K | 0.02% | 457 |
|
|
2018
Q4 | $1.19M | Buy |
6,333
+886
| +16% | +$164K | 0.02% | 400 |
|
|
2018
Q3 | $927K | Buy |
5,447
+84
| +2% | +$14.1K | 0.02% | 429 |
|
|
2018
Q2 | $879K | Buy |
5,363
+733
| +16% | +$120K | 0.02% | 428 |
|
|
2018
Q1 | $749K | Buy |
4,630
+616
| +15% | +$98.1K | 0.03% | 365 |
|
|
2017
Q4 | $587K | Buy |
4,014
+1,385
| +53% | +$197K | 0.02% | 366 |
|
|
2017
Q3 | $357K | Sell |
2,629
-514
| -16% | -$64.9K | 0.02% | 396 |
|
|
2017
Q2 | $394K | Sell |
3,143
-17,657
| -85% | -$2.11M | 0.02% | 378 |
|
|
2017
Q1 | $2.47M | Sell |
20,800
-634
| -3% | -$76.3K | 0.11% | 164 |
|
|
2016
Q4 | $2.47M | Sell |
21,434
-1,146
| -5% | -$128K | 0.11% | 158 |
|
|
2016
Q3 | $2.36M | Buy |
22,580
+604
| +3% | +$63.1K | 0.11% | 164 |
|
|
2016
Q2 | $2.14M | Buy |
21,976
+10,792
| +96% | +$1.02M | 0.12% | 162 |
|
|
2016
Q1 | $1.07M | Buy |
11,184
+6,184
| +124% | +$563K | 0.06% | 236 |
|
|
2015
Q4 | $453K | Hold |
5,000
| – | – | 0.03% | 296 |
|
|
2015
Q3 | $464K | Buy |
+5,000
| New | +$475K | 0.02% | 341 |
|
Other funds holding CME
VCM
VPM
Mariner's CME Position: Q1 2026 in Review
Mariner increased its CME Group (CME) stake by 4.6% in Q1 2026, buying an estimated $4.68M and bringing the position to 357,919 shares worth $106M. The position accounts for 0.12% of the portfolio, ranked #145.
Mariner first reported a position in CME in Q3 2015 and has held it in 41 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Mariner held 357,919 shares of CME Group worth $106M as of Q1 2026.
- Mariner bought 15,753 CME Group shares in Q1 2026, an estimated $4.68M.
- CME Group made up 0.12% of Mariner's portfolio in Q1 2026, its #145 holding.
- Mariner first reported a position in CME Group in Q3 2015 and has held it in 41 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.